Lorlatinib is for treating advanced non-small cell lung cancer, specifically the kind with an ALK mutation that’s stopped responding to other ALK inhibitors. Lorlatinib is a third-generation ALK and ROS1 inhibitor. It’s mainly used to target and stop these specific kinase proteins, which help cancer cells to grow.
The drug comes in two doses, 25 mg and the stronger 100 mg, both in coated tablets. The doc usually suggests taking 100 mg of the stuff once each day, whether with meals or not is up to you. You’ll find these tablets in bottles, with 30 of them in each one.
The stuff in lorlatinib works by stopping the action of ALK and ROS1 proteins. These are like little helpers that tell cancer cells to grow out of control. This kind of targeted treatment comes in after other ALK inhibitors don’t work anymore.
It’s like a fresh chance for people with the nastier advanced stuff.
